Valerie Pilorget
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Effectiveness and Safety of Insulin Glargine 300 U/ml in High-Risk Subgroups (Renal Impairment and Older Age ≥ 70 years) of Insulin-Naïve People with Type 2 Diabetes: A Post hoc Analysis of Real-World ATOS Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 14, 2025
Real-world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12-month, prospective observational study.
Journal: Diabetes, obesity & metabolism
Published: December 13, 2023
Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study.
Journal: Diabetes & metabolic syndrome
Published: October 20, 2022
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Journal: Diabetes, obesity & metabolism
Published: August 23, 2022
Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 05, 2022
Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 01, 2022
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 25, 2020
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 04, 2020
The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM.
Journal: Diabetes/metabolism research and reviews
Published: April 07, 2020
Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study.
Journal: Diabetes research and clinical practice
Published: February 07, 2020
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus.
Journal: Current medical research and opinion
Published: December 24, 2019
InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 06, 2019
Last Updated: 09/26/2026